Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled clinical trials in stroke.

C Fieschi1, M Frontoni, C Argentino

  • 1Department of Neurosciences, University of Rome La Sapienza, Italy.

Arzneimittel-Forschung
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The organisation of the acute ischemic stroke management: key notes of the Italian Neurological Society and of the Italian Stroke Organization.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2017
Same author

Declining incidence of intracerebral hemorrhage over two decades in a population-based study.

European journal of neurology·2016
Same author

Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2016
Same author

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

Leukemia·2016
Same author

Evaluation of medical therapies of acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

[Lung disease in adult common variable immunodeficiency].

Revue des maladies respiratoires·2015
Same journal

Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

Arzneimittel-Forschung·2013
Same journal

Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

Arzneimittel-Forschung·2013
Same journal

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012
Same journal

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012
Same journal

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012
Same journal

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012
See all related articles

Clinical trials for acute cerebral ischemia face challenges. Early intervention with fibrinolytics and neuroprotectants shows promise for future acute ischemic stroke treatment.

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Trials

Background:

  • Most clinical trials for acute cerebral ischemia lack sufficient reliability and numbers.
  • Current pathophysiological understanding supports the critical window for early intervention.

Purpose of the Study:

  • To review the clinical aspects hindering reliable trials in acute cerebral ischemia.
  • To evaluate past and recent Italian trials focusing on early intervention within 6 hours of stroke onset.
  • To identify promising future therapeutic strategies for acute ischemic stroke.

Main Methods:

  • Review of existing literature on pharmacological treatments for acute cerebral ischemia.
  • Analysis of clinical trial data from Italian studies on ischemic stroke patients treated within 6 hours.

Related Experiment Videos

  • Inclusion of results from a study incorporating early cerebral angiography and SPECT (Single Photon Emission Computed Tomography).

    • Main Results:

    • Identified key clinical factors contributing to the inadequacy of current trial data.
    • Reported outcomes from Italian trials demonstrating the evaluation and treatment of acute ischemic stroke patients within the critical early window.
    • Highlighted the potential of advanced imaging techniques like SPECT in assessing early stroke.

    Conclusions:

    • Early intervention is crucial for improving outcomes in acute cerebral ischemia.
    • Future clinical trials should focus on early administration of fibrinolytics combined with brain-protecting agents.
    • Integrating advanced imaging like SPECT may enhance the reliability and success of acute stroke treatment trials.